Standard Chem & Pharm Co Ltd
TWSE:1720

Watchlist Manager
Standard Chem & Pharm Co Ltd Logo
Standard Chem & Pharm Co Ltd
TWSE:1720
Watchlist
Price: 63.6 TWD 0.47% Market Closed
Market Cap: 11.4B TWD
Have any thoughts about
Standard Chem & Pharm Co Ltd?
Write Note

Standard Chem & Pharm Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Standard Chem & Pharm Co Ltd
Operating Income Peer Comparison

Comparables:
Y
3705
4746
1789
S
4119
1795

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Standard Chem & Pharm Co Ltd
TWSE:1720
Operating Income
NT$1.3B
CAGR 3-Years
21%
CAGR 5-Years
25%
CAGR 10-Years
16%
Y
YungShin Global Holding Corp
TWSE:3705
Operating Income
NT$1.1B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
4%
Formosa Laboratories Inc
TWSE:4746
Operating Income
NT$737.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
12%
ScinoPharm Taiwan Ltd
TWSE:1789
Operating Income
NT$442.1m
CAGR 3-Years
8%
CAGR 5-Years
-1%
CAGR 10-Years
-7%
S
SCI Pharmtech Inc
TWSE:4119
Operating Income
NT$145.3m
CAGR 3-Years
-35%
CAGR 5-Years
-26%
CAGR 10-Years
-5%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Operating Income
NT$4.5B
CAGR 3-Years
27%
CAGR 5-Years
38%
CAGR 10-Years
55%

See Also

What is Standard Chem & Pharm Co Ltd's Operating Income?
Operating Income
1.3B TWD

Based on the financial report for Jun 30, 2024, Standard Chem & Pharm Co Ltd's Operating Income amounts to 1.3B TWD.

What is Standard Chem & Pharm Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
16%

Over the last year, the Operating Income growth was 8%. The average annual Operating Income growth rates for Standard Chem & Pharm Co Ltd have been 21% over the past three years , 25% over the past five years , and 16% over the past ten years .

Back to Top